Anti-invasion effects of 6-shogaol and 6-gingerol, two active components in ginger, on human hepatocarcinoma cells

Molecular Nutrition and Food Research

Volumn 54, Issue 11, 2010, Pages 1618-1627

  Weng, Chia Jui ^a,b   Wu, Cheng Feng ^a   Huang, Hsiao Wen ^a   Ho, Chi Tang ^c   Yen, Gow Chin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b TAINAN UNIVERSITY OF TECHNOLOGY   (Taiwan)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

6 Gingerol; 6 Shogaol; Invasion; Matrix metalloproteinases; Tissue inhibitor metalloproteinase

Indexed keywords

CATECHOL DERIVATIVE; FATTY ALCOHOL; GELATINASE A; GELATINASE B; GINGEROL; MMP2 PROTEIN, HUMAN; SHOGAOL; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CANCER INVASION; CELL STRAIN HEPG2; CHEMISTRY; GINGER; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

CARCINOMA, HEPATOCELLULAR; CATECHOLS; FATTY ALCOHOLS; GINGER; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

ZINGIBER OFFICINALE;

EID: 78349245958     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000108     Document Type: Article

References (38)

1. Dorai, T., Aggarwal, B. B., Role of chemopreventive agents in cancer therapy. Cancer Lett. 2004, 215, 129-140.
2. Park, K. K., Chun, K. S., Lee, J. M., Lee, S. S. et al., Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett. 1998, 129, 139-144.
3. Manju, V., Nalini, N., Chemopreventive efficacy of ginger, a naturally occurring anticarcinogen during the initiation, postinitiation stages of 1, 2 dimethylhydrazine-induced colon cancer. Clin. Chim. Acta 2005, 358, 60-67.
4. Lantz, R. C., Chen, G. J., Sarihan, M., Solyom, A. M. et al., The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine 2007, 14, 123-128.
5. O'Hara, M., Kiefer, D., Farrell, K., Kemper, K., A review of 12 commonly used medicinal herbs. Arch. Fam. Med. 1998, 7, 523-536.
6. Akagi, K., Hirose, M., Hoshiya, T., Mizoguchi, Y. et al., Modulating effects of ellagic acid, vanillin and quercetin in a rat medium term multi-organ carcinogenesis model. Cancer Lett. 1995, 94, 113-121.
7. Surh, Y. J., Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res. 1999, 428, 305-327.
8. Mahmoud, N. N., Carothers, A. M., Grunberger, D. R., Bilinski, T. et al., Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 2000, 21, 921-927.
9. Kyung, K. S., Gon, J. H., Geun, K. Y., Sup, J. J. et al., 6-Shogaol, a natural product, reduces cell death and restores motor function in rat spinal cord injury. Eur. J. Neurosci. 2006, 24, 1042-1052.
10. Pan, M. H., Hsieh, M. C., Hsu, P. C., Ho, S. Y. et al., 6-Shogaol suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. Mol. Nutr. Food Res. 2008, 52, 1467-1477.
11. Surh, Y. J., Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem. Toxicol. 2002, 40, 1091-1097.
12. Wang, C. C., Chen, L. G., Lee, L. T., Yang, L. L., Effects of 6-gingerol, an antioxidant from ginger, on inducing apoptosis in human leukemic HL-60 cells. In Vivo 2003, 17, 641-645.
13. Suzuki, F., Kobayashi, M., Komatsu, Y., Kato, A. et al., Keishi-ka-kei-to, a traditional Chinese herbal medicine, inhibits pulmonary metastasis of B16 melanoma. Anticancer Res. 1997, 17, 873-878.
14. Yagihashi, S., Miura, Y., Yagasaki, K., Inhibitory effect of gingerol on the proliferationand invasion of hepatoma cells in culture. Cytotechnology 2008, 57, 129-136.
15. Isa, Y., Miyakawa, Y., Yanagisawa, M., Goto, T. et al., 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-alpha mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2008, 373, 429-434.
16. Pan, M. H., Hsieh, M. C., Kuo, J. M., Lai, C. S. et al., 6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, and GADD 153 expression. Mol. Nutr. Food Res. 2008, 52, 527-537.
17. Parkin, D. M., Bray, F., Ferlay, J., Pisani, P., Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55, 74-108.
18. Westermarck, J., Kahari, V. M., Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999, 13, 781-792.
19. Stetler-Stevenson, W. G., Yu, A. E., Proteases in invasion: matrix metalloproteinases. Semin. Cancer Biol. 2001, 11, 143-152.
20. Rao, J. S., Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 2003, 3, 489-501.
21. Nelson, A. R., Fingleton, B., Rothenberg, M. L., Matrisian, L. M., Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol. 2000, 18, 1135-1149.
22. Chung, T. W., Moon, S. K., Lee, Y. C., Kim, J. G. et al., Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells. Arch. Biochem. Biophys. 2002, 408, 147-154.
23. Sugita, K., Recent advances in inhibitors of metalloproteinases for cancer therapy. IDrugs 1999, 2, 327-339.
24. Jinga, D. C., Blidaru, A., Condrea, I., Ardeleanu, C. et al., MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors. J. Cell Mol. Med. 2006, 10, 499-510.
25. Weng, C. J., Wu, C. F., Huang, H. W., Wu, C. H. et al., Evaluation of anti-invasion effect of resveratrol and related methoxy analogues on human hepatocarcinoma cells. J. Agric. Food Chem. 2010, 58, 2886-2894.
26. Repesh, L. A., A new in vitro assay for quantitating tumor cell invasion. Invas. Metast. 1989, 9, 192-208.
27. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
28. Rhode, J., Fogoros, S., Zick, S., Wahl, H. et al., Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC Complement Altern. Med. 2007, 7, 44-52.
29. Lee, H. S., Seo, E. Y., Kang, N. E., Kim, W. K., [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J. Nutr. Biochem. 2008, 19, 313-319.
30. Kim, E. C., Min, J. K., Kim, T. Y., Lee, S. J. et al., [6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo. Biochem. Biophys. Res. Commun. 2005, 335, 300-308.
31. Boyland, E., Chasseaud, L. F., Enzymes catalysing conjugations of glutathione with alpha-beta-unsaturated carbonyl compounds. Biochem. J. 1968, 109, 651-661.
32. Atsmon, J., Freeman, M. L., Meredith, M. J., Sweetman, B. J. et al., Conjugation of 9-deoxy-delta 9, delta 12(E)-prostaglandin D2 with intracellular glutathione and enhancement of its antiproliferative activity by glutathione depletion. Cancer Res. 1990, 50, 1879-1885.
33. Schrohl, A. S., Meijer-van Gelder, M. E., Holten-Andersen, M. N., Christensen, I. J. et al., Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer. Clin. Cancer Res. 2006, 12, 7054-7058.
34. Davidsen, M. L., Würtz, S. Ø., Rømer, M. U., Sørensen, N. M. et al., TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy induced apoptosis. Br. J. Cancer 2006, 95, 1114-1120.
35. Lacraz, S., Nicod, L. P., Chicheportiche, R., Welgus, H. G. et al., IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J. Clin. Invest. 1995, 96, 2304-2310.
36. Joo, Y. E., Seo, Y. H., Lee, W. S., Kim, H. S. et al., Expression of tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma. Korean J. Intern. Med. 2000, 15, 171-178.
37. Weng, C. J., Chau, C. F., Hsieh, Y. S., Yang, S. F. et al., Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Carcinogenesis 2008, 29, 147-156.
38. Wang, S. P., Wang, W. L., Chang, Y. L., Wu, C. T. et al., p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat. Cell Biol. 2009, 11, 694-704.